• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Can/Fite

Recent news which mentions Can/Fite

Industry Analysts Seemingly Sing Praises For This Stock After Phase III Trial Results
July 14, 2022
Tickers CANF JNJ MRK PFE
Tags Market News Can/Fite CANF
From Benzinga
CANF: Beginning to Flex Its Muscles; Initiating With OUTPERFORM Rating, $6.00 Price Target
February 23, 2022
Tickers CANF
Tags Market News CANF Can/Fite
From Benzinga
Piclidenoson Takes On Otezla, a $13 Billion Psoriasis Drug
December 14, 2021
Tickers AMGN CANF CELG PFE
Tags Benzinga Partner Content PFE
From Benzinga
Race to Effective Psoriasis Treatment: Can-Fite's Piclidenoson May Edge Over High-Flying Amgen's Otezla. Here's Why
October 20, 2021
Tags Market News Health Care Markets
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap